These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 463410)

  • 1. [Glucose assimilation under high-dose norethisterone-acetate therapy in adenocarcinoma of the corpus uteri].
    Starker W; Fricke HJ
    Zentralbl Gynakol; 1979; 101(7):473-7. PubMed ID: 463410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of high dosage progesterone therapy in carcinoma corporis uteri].
    Seewald HJ; Böhm W; Przesang R
    Zentralbl Gynakol; 1977; 99(7):392-5. PubMed ID: 868363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectivity of long-term high dose norethisterone treatment of corpus uteri carcinoma patients. Results of a prospective randomized study].
    Behling H; Krafft W; Schmeisser G; Schirmer A; Preibsch W; Brückmann D
    Zentralbl Gynakol; 1983; 105(9):553-9. PubMed ID: 6880470
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of an adjuvant norethisterone acetate therapy (NEA) of endometrial carcinoma treated with primary surgery or irradiation].
    Krafft W; Steuckardt R; König EM; Schirmer A; Schmeisser G; Brückmann D
    Zentralbl Gynakol; 1990; 112(16):1023-30. PubMed ID: 2220176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. II. Influence on carbohydrate metabolism].
    Lanza A
    Minerva Ginecol; 1969 Dec; 21(23):1624-31. PubMed ID: 5373231
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of lynestrenol and norethindrone on the carbohydrate and lipid metabolism in subjects with gestational diabetes.
    Pyörälä T; Vähäpassi J; Huhtala M
    Ann Chir Gynaecol; 1979; 68(2):69-74. PubMed ID: 507743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The place of high doses of synthetic progesterone and progestogens in treatment of adenocarcinoma of the corpus uteri].
    Muller P; Keller B; Levy G; Charton B
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(4):386-9. PubMed ID: 5713737
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J; Hammar M
    Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Criticism of the K value-utility and evidence of the glucose assimilation coefficient].
    Möricke R; Caruso M; Andraczek F
    Z Gesamte Inn Med; 1980 Apr; 35(8):325-30. PubMed ID: 7434841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable norethisterone enanthate contraception: absence of an effect on oral glucose tolerance.
    Giwa-osagie OF; Newton JR
    Contracept Deliv Syst; 1982 Jan; 3(1):61-2. PubMed ID: 12264129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
    Spellacy WN; Ellingson AB; Tsibris JC
    J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of diftalone on tolbutamide test and i.v. glucose tolerance test.
    Scherak O; Weissel M; Fritzsche H; Kolarz G
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):86-92. PubMed ID: 1087282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
    Piver MS; Lele S; Barlow JJ
    Obstet Gynecol; 1980 Sep; 56(3):370-2. PubMed ID: 7422177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
    Fliser D; Rett K; Hübinger A; Ritz E
    Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate?
    Muneyyirci-Delale O; Jalou S; Rahman M; Nacharaju V
    Int J Fertil Womens Med; 2003; 48(1):32-6. PubMed ID: 12643518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and metabolic effects of low-dose estrogen-progestin treatment in climacteric women.
    Ylöstalo P; Kauppila A; Kivinen S; Tuimala R; Vihko R
    Obstet Gynecol; 1983 Dec; 62(6):682-6. PubMed ID: 6355937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.